|
- Fit Testing | Personal Protective Equipment | CDC
The test is a pass fail test that determines whether you can detect a test agent, such as through taste, smell, or an involuntary cough The OSHA-accepted fit test protocols provide complete instructions for conducting qualitative fit tests with the accepted test agents NIOSH does not endorse or recommend the use of the irritant smoke fit test
- Testing for COVID-19 | COVID-19 | CDC
Getting a COVID-19 test Buy self-tests (at-home tests) Buy self-tests (at-home tests) online or in pharmacies and retail stores If you have health insurance, it may reimburse the cost of purchasing self-tests Visit FDA's website for a list of authorized tests Go to a testing location Visit a community-based testing location, such as a pharmacy or health center near you These locations may
- Overview of Testing for SARS-CoV-2 | COVID-19 | CDC
This overview describes current information on the types of tests used to detect SARS-CoV-2 infection and their intended uses This information is intended for use by healthcare providers, public health professionals, and those organizing and implementing testing in non-healthcare settings
- Information for Diagnostic Laboratories | Rabies | CDC
The LN34 PCR test for rabies is a newer diagnostic test that uses real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) methodology to detect the presence of rabies virus genetic material
- Laboratory Testing for CMV and Congenital CMV
The enzyme-linked immunosorbent assay is the most common serologic test for measuring antibody to CMV Congenital CMV infection cannot be diagnosed with antibody testing (IgG and IgM) The standard laboratory test for diagnosing congenital CMV infection is a PCR on saliva, with a confirmatory test on urine
- Laboratory Testing for Epstein-Barr Virus (EBV)
Laboratory testing can help distinguish whether someone is susceptible to EBV infection or has a recent or past infection Healthcare providers can test for antibodies to specific EBV-associated antigens Monospot test is not recommended for general use
- Clinical Testing and Diagnosis for Tuberculosis
For more details on interpreting TB skin test results, please visit Clinical Testing Guidance for Tuberculosis: Tuberculin Skin Test TB skin results should only be read by a trained health care professional Consult with your state and local public health authorities to determine who is authorized to place and read TB skin tests in your state
- Clinical Testing and Diagnosis for Lyme Disease
Laboratory diagnosis of Lyme disease relies on serologic testing for antibodies to Borrelia burgdorferi CDC recommends a two-step serologic testing process using FDA-cleared assays Serologic assays may be falsely negative during the first 4-6 weeks after infection Before CDC will recommend new tests, they must be cleared by the Food and Drug Administration (FDA)
|
|
|